18 parallel-processing-bioinformatics-"Study-Group" Fellowship positions at Northeastern University
Sort by
Refine Your Search
-
. NLP & IR 3.0: This area covers the study of large language models and other natural language processing techniques applied to language understanding and the next generation of search engines. AI
-
environment of the group. The associate will be expected to conduct independent research, contribute to the mentorship of junior lab members, and communicate findings through publications
-
Processing (NLP) and Computer Vision (CV) - strong record of publications - Excellent communication skills and ability to work in a fast-paced and innovative setting Preferred Qualifications (Project 1
-
field; Experience with EEG signal processing and study design; Statistical analysis skills for brain analyses; and Strong communication skills and ability to work both within a team and independently
-
clinical study results. Fellows can also expect to contribute to strategic medical planning, champion congress engagements, support the development of medical materials, and collaborate with leaders from
-
programs at Vertex, working on cross-functional study teams for the design, execution, and monitoring of clinical trials, as well as assisting with data interpretation and communication. This role
-
submission. They are data-driven, scientific leaders of programs in the clinical stage, with key responsibilities in clinical research and study execution. The fellow will develop a deep understanding of the
-
existing data, which can range broadly from behavioral (e.g., computerized task) to neuroimaging (e.g., fMRI) data from studies examining neurodevelopmental mechanisms of social information processing
-
. Communicate results in laboratory group meetings, scientific conferences, and publications. Prepare progress reports, presentations, manuscripts, and patent applications. Participate in professional
-
of clinical study reports and provide support to regulatory documents Modeling and Simulation Rotation: • Implement model informed drug development (MIDD) using quantitative approaches (e.g